Ser371
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser371  -  RARG (human)

Site Information
YARRRRPsQPYMFPR   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 62884000

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 , 2 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Disease tissue studied:
breast cancer ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
Akt1 (human) ( 1 )
Treatments:
Akt_inhibitor_VIII ( 1 )

Downstream Regulation
Effects of modification on RARG:
activity, induced ( 1 )

References 

1

Sugimoto K, et al. (2019) Cell adhesion signals regulate the nuclear receptor activity. Proc Natl Acad Sci U S A 116, 24600-24609
31740618   Curated Info

2

Chebaro Y, et al. (2017) Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptor╬│. PLoS One 12, e0171043
28125680   Curated Info